SCHEMBL458476

SCHEMBL458476

COc1ccccc1/C=C/C(=O)NN

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFE2L2 Q16236 2/20 0.69
▸ TFEB P19484 1/20 0.68
▸ KDM4E B2RXH2 4/20 0.66
▸ NPC1 O15118 5/20 0.60
▸ LMNA P02545 4/20 0.60
▸ MAPT P10636 4/20 0.60
▸ RAB9A P51151 3/20 0.60
▸ BCHE P06276 1/20 0.60
▸ TRPA1 O75762 1/20 0.60
▸ TRPM8 Q7Z2W7 1/20 0.60
▸ HPGD P15428 3/20 0.59
▸ MEN1 O00255 2/20 0.59
▸ KMT2A Q03164 2/20 0.59
▸ ALDH1A1 P00352 2/20 0.59
▸ ALOX12 P18054 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ ATM Q13315 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ TDP1 Q9NUW8 1/20 0.59
▸ LY96 Q9Y6Y9 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL458477 1.00 NFE2L2 (0.69) NFE2L2TFEBKDM4ENPC1LMNA
Methylamine SCHEMBL15948926 0.98 NFE2L2 (0.67) NFE2L2TFEBKDM4ENPC1LMNA
SCHEMBL31482418 0.87 NFE2L2 (0.73) NFE2L2TFEBKDM4ENPC1LMNA
SCHEMBL25624793 0.85 NFE2L2 (0.71) NFE2L2TFEBKDM4ENPC1LMNA
SCHEMBL14244731 0.85 NFE2L2 (0.71) NFE2L2TFEBKDM4ENPC1LMNA
SCHEMBL12426056 0.85 NFE2L2 (0.71) NFE2L2TFEBKDM4ENPC1LMNA
SCHEMBL30071669 0.83 NFE2L2 (0.68) NFE2L2TFEBKDM4ENPC1LMNA
SCHEMBL5424482 0.83 NFE2L2 (0.68) NFE2L2TFEBKDM4ENPC1LMNA
SCHEMBL5427611 0.83 NFE2L2 (0.68) NFE2L2TFEBKDM4ENPC1LMNA
SCHEMBL458059 0.83 LMNA (0.58) NFE2L2TFEBKDM4ENPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853276-B2 Guanidine derivatives in cinnamic series PRODUITS CHIMIQUES AUXILIAIRES ET DE SYNTHESE (FR) 2014-10-07 — — US disclosed
EP-2614046-B1 NOVEL GUANIDINE DERIVATIVES IN THE CINNAMIC SERIES PROD CHIM AUXILIAIRES ET DE SYNTHESE (FR) 2014-08-20 — — EP disclosed
EP-2614046-A1 NOVEL GUANIDINE DERIVATIVES IN THE CINNAMIC SERIES Produits Chimiques Auxiliaires et de Synthese (FR) 2013-07-17 — — EP disclosed
US-20130165507-A1 NEW GUANIDINE DERIVATIVES IN CINNAMIC SERIES PRODUITS CHIMIQUES AUXILIAIRES ET DE SYNTHESE (FR) 2013-06-27 — — US disclosed
WO-2012032257-A1 NOVEL GUANIDINE DERIVATIVES IN THE CINNAMIC SERIES PRODUITS CHIMIQUES AUXILIAIRES ET DE SYNTHESE (FR) 2012-03-15 — — WO disclosed
US-4232106-A Photosensitive compositions containing 2-halomethyl-5-vinyl-1,3,4-oxadiazoles as free radical progenitors FUJI PHOTO FILM CO., LTD. (JP) 1980-11-04 — — US disclosed
US-4212970-A PHOTOINITIATORS FUJI PHOTO FILM CO., LTD. (JP) 1980-07-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165507-A1 NEW GUANIDINE DERIVATIVES IN CINNAMIC SERIES GMPS, UNG, AGER NFE2L2 353/4885TFEB 1284/4885KDM4E 1037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback